פוסטימון 75 IU ישראל - עברית - Ministry of Health

פוסטימון 75 iu

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 75 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

פוסטימון 150 IU ישראל - עברית - Ministry of Health

פוסטימון 150 iu

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 150 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

ברבל ישראל - עברית - Ministry of Health

ברבל

ferring pharmaceuticals ltd - urofollitrophin highly purified (hpfsh) 75 iu/vial - powder for solution for injection - urofollitropin - anovulation (including polycystis ovarian disease (pcod) in women who have been unresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (evf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

פיפרצין 4 גרם ישראל - עברית - Ministry of Health

פיפרצין 4 גרם

vitamed ltd,binyamina - piperacillin as sodium 4 g/vial - powder for solution for injection - piperacillin - for the treatment and prophylaxis of systemic and local infections due to susceptible gram (-) and gram ( +) aerobic and anaerobic bacteria.

פניצילין G סודיום  5 MU ישראל - עברית - Ministry of Health

פניצילין g סודיום 5 mu

teva israel ltd - benzylpenicillin sodium - אבקה להכנת תמיסה לזריקה - benzylpenicillin sodium 5 miu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin sensitive organisms.

פניצילין G סודיום 10 M.U ישראל - עברית - Ministry of Health

פניצילין g סודיום 10 m.u

teva israel ltd - benzylpenicillin sodium - אבקה להכנת תמיסה לזריקה - benzylpenicillin sodium 10 mu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin - sensitive microorganisms.

קלבמוקס 1 גרם זריקות ישראל - עברית - Ministry of Health

קלבמוקס 1 גרם זריקות

taro international ltd - amoxicillin as sodium 1 g/vial; clavulanic acid as sodium 200 mg/vial - solution for injection - amoxicillin and enzyme inhibitor - clavamox is indicated for short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactamase antibiotics.

טאזוצין 2.25 גרם ישראל - עברית - Ministry of Health

טאזוצין 2.25 גרם

neopharm ltd - piperacillin as sodium 2 g/vial; tazobactam sodium 0.25 g/vial - powder for solution for injection - piperacillin and enzyme inhibitor - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

טימנטין 3.2 ג' ישראל - עברית - Ministry of Health

טימנטין 3.2 ג'

glaxo smith kline (israel) ltd - clavulanic acid as potassium 200 mg/vial; ticarcillin disodium 3 g/vial - powder for solution for infusion - combinations of penicillins - timentin is an injectable antibiotic agent with a broad spectrum of bactericidal activity against a wide range of gram-positive and gram-negative, aerobic and anaerobic bacteria. the presence of clavulanate in the formulation extends the spectrum of activity of ticarcillin to include many beta-lactamase producing bacteria normally resistant to ticarcillin and other beta-lactam antibiotics. timentin is indicated for the treatment of infections in which susceptible organisms have been detected or are suspected. typical indications include: severe infections in hospitalised patients and proven or suspected infections in patients with impaired or suppressed host defences including: septicaemia, bacteraemia, peritonitis, intra-abdominal sepsis, post-surgical infections, bone and joint infections, skin and soft tissue infections, respiratory tract infections, serious or complicated renal infections (e.g. pyelonephritis), ear, nose and throat infections.

טימנטין 3.2 ג' ישראל - עברית - Ministry of Health

טימנטין 3.2 ג'

glaxo smith kline (israel) ltd - clavulanic acid as potassium 200 mg/vial; ticarcillin as disodium 3 g/vial - powder for solution for infusion - combinations of penicillins - timentin is an injectable antibiotic agent with a broad spectrum of bactericidal activity against a wide range of gram-positive and gram-negative, aerobic and anaerobic bacteria. the presence of clavulanate in the formulation extends the spectrum of activity of ticarcillin to include many beta-lactamase producing bacteria normally resistant to ticarcillin and other beta-lactam antibiotics. timentin is indicated for the treatment of infections in which susceptible organisms have been detected or are suspected. typical indications include: severe infections in hospitalised patients and proven or suspected infections in patients with impaired or suppressed host defences including: septicaemia, bacteraemia, peritonitis, intra-abdominal sepsis, post-surgical infections, bone and joint infections, skin and soft tissue infections, respiratory tract infections, serious or complicated renal infections (e.g. pyelonephritis), ear, nose and throat infections.